MedTrace Logo

Mitochondrial Disease-associated ImmunoDeficiencies

NCT06213103 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-02-03

No results posted yet for this study

Summary

The study aims at characterizing the immune dysfunctions in patients with mitochondrial diseases. This has prognostic and diagnostic interest as well as potential for the discovery of new therapeutic strategies to alleviate disease burden.

Conditions

  • Mitochondrial Disorders

Interventions

PROCEDURE

Patient cohort

Collection of 6 blood tubes at the inclusion visit.

PROCEDURE

Control cohort

Collection of 6 blood tubes at the inclusion visit.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Aurélien TRIMOUILLE, MD · University Hospital, Bordeaux

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06213103 on ClinicalTrials.gov